Pharmacokinetic/pharmacodynamic studies in drug product development.
about
Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study.In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TBComputer-aided retrometabolic drug design: soft drugs.Concepts and challenges in quantitative pharmacology and model-based drug development.The Role of Pharmacokinetics and Pharmacodynamics in Early Drug Development with reference to the Cyclin-dependent Kinase (Cdk) Inhibitor - RoscovitineIntegration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.Quantitative PK-PD model-based translational pharmacology of a novel kappa opioid receptor antagonist between rats and humans.Safety and efficacy: the role of chemistry, manufacturing, and controls in pharmaceutical drug development.A Systems Biology Approach in Therapeutic Response Study for Different Dosing Regimens-a Modeling Study of Drug Effects on Tumor Growth using Hybrid SystemsExposure-response model for sibutramine and placebo: suggestion for application to long-term weight-control drug developmentApplications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives.A simple in vitro PK/PD model system to determine time-kill curves of drugs against Mycobacteria.The in silico child: using simulation to guide pediatric drug development and manage pediatric pharmacotherapy.Tissue Penetration of a Novel Spectinamide Antibiotic for the Treatment of Tuberculosis.Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling.Role of modelling and simulation: a European regulatory perspective.The current role of model-based drug development.Application of microdialysis for pharmacokinetic-pharmacodynamic modelling.Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides.Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening.Tools for predicting the PK/PD of therapeutic proteins.Integrating internal and external bioanalytical support to deliver a diversified pharmaceutical portfolio.Recommendations for the development and validation of flow cytometry-based receptor occupancy assays.Drug Development of Therapeutic Monoclonal Antibodies.Whither pharmacometrics?: present state and future choices.Discovery DMPK: changing paradigms in the eighties, nineties and noughties.Microtechnology-Based Multi-Organ Models.Pharmacokinetics of antofloxacin hydrochloride, a novel fluoroquinolone, after single-dose intravenous administration in healthy Chinese male volunteers.Model-based decision making in early clinical development: minimizing the impact of a blood pressure adverse event.Mathematical modeling of efficacy and safety for anticancer drugs clinical development.Relationship between blood levels and the anti-hyperalgesic effect of ketoprofen in the rat.Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization.Pharmacokinetics and Half-Life of Protein TherapeuticsPharmacokinetics and Pharmacodynamics of Therapeutic Peptides and ProteinsPharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs
P2860
Q33392904-59A0163A-C9E8-4BFB-801F-D642534CF217Q34591451-C1DF6AC9-E0D5-46A0-9D75-C070675855A5Q34619242-CE9F591E-1672-4FA4-A49B-0B781FDCF414Q34878168-33258416-6CA7-4816-A857-366575481F6DQ35062145-73513A8D-922F-496D-AD0F-A6550C8B9250Q35127800-D57FAEE8-6693-46A2-81A9-A30E35729B37Q35595776-BB90A677-E29B-4D13-970E-2A8F5CB331BBQ35756163-307DF39B-5933-4EA4-8CED-3199E00E4099Q35817902-7E70CDBE-3E4A-4371-83F3-EE1FA449E03DQ36068367-311E16C8-92E1-4864-86AB-F3A2A51C69D4Q37259653-B5D20ED8-A8EA-4887-B712-3AD73A57D96BQ37441394-A08B20BE-CB51-4F1F-A83B-8C3A09028E1EQ37521422-519EBF26-99BA-4AE0-BA7A-7811C2957E46Q37600402-D839F117-E604-4D66-AF5B-2BEB38B36918Q37764345-AA64CFD7-3688-4EA4-B26C-892B685B4DB1Q37976876-A34772DD-89EA-476F-AFE0-22E482766C61Q38028538-E3A26074-A95C-4691-8F94-BAF057FB3BADQ38089788-68434696-185D-478D-B50F-D3DBAA566BADQ38110433-287EF63C-BC0B-4671-9B09-5EA7DD3D92FEQ38137976-9888F757-FD5B-4171-A2DB-B0EF78A2DBB3Q38455786-43B91EF0-1993-46F0-B478-49969E0EE2BAQ38563482-23EAB79B-6EDF-452B-B946-CF04D30470D2Q38632834-7202AA12-0616-47B1-9D1B-50390821BF85Q38876360-CDB08131-868D-4A45-95FF-B33A666C3837Q39189602-FBE9066F-5D29-45A4-929F-27ABF4ECDF00Q39998934-4E1360A9-D3AC-4976-B2F6-E04F344B4E31Q41704262-6D873DEE-0A34-4E88-A7CE-6F2534E60D39Q43129465-8404050E-1EA9-4098-9E49-A17880282740Q43150883-70479F4D-72E9-4B93-B6F2-89FB4EA56648Q47663303-F99D4244-86DB-49FE-A865-158541B315A4Q51100991-AD3674D5-54E6-464F-8E13-A54114D9E3D8Q51306832-F91AB0B2-8E04-4A0C-B876-FE37AAA2724DQ58869604-DF457BB8-15A2-4038-A2C6-0FB9606CD6ECQ58869607-BDF64B98-BF06-44C0-B197-A455D0AD72DAQ58869645-D0E0920E-0B98-46D7-A380-B786554EBA71
P2860
Pharmacokinetic/pharmacodynamic studies in drug product development.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pharmacokinetic/pharmacodynamic studies in drug product development.
@ast
Pharmacokinetic/pharmacodynamic studies in drug product development.
@en
Pharmacokinetic/pharmacodynamic studies in drug product development.
@nl
type
label
Pharmacokinetic/pharmacodynamic studies in drug product development.
@ast
Pharmacokinetic/pharmacodynamic studies in drug product development.
@en
Pharmacokinetic/pharmacodynamic studies in drug product development.
@nl
prefLabel
Pharmacokinetic/pharmacodynamic studies in drug product development.
@ast
Pharmacokinetic/pharmacodynamic studies in drug product development.
@en
Pharmacokinetic/pharmacodynamic studies in drug product development.
@nl
P356
P1476
Pharmacokinetic/pharmacodynamic studies in drug product development.
@en
P2093
Bernd Meibohm
Hartmut Derendorf
P356
10.1002/JPS.1167
P407
P577
2002-01-01T00:00:00Z